Brain metastasis is a major cause of mortality and is more frequent in patients with human epidermal growth factor receptor 2+ (HER2+) or triple-negative breast cancer (TNBC) [3–5]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.